114 related articles for article (PubMed ID: 22129577)
21. Placental Pathology in Maternal Ornithine Transcarbamylase Deficiency.
Seasely AR; Sinkey RG; Dean SJ; Descartes M; Duncan VE
Pediatr Dev Pathol; 2022; 25(3):278-284. PubMed ID: 34958254
[TBL] [Abstract][Full Text] [Related]
22. Neuromyelitis Optica Complicated by Ornithine Transcarbamylase Deficiency Treated Safely with Pulse Steroid Therapy.
Yoshida R; Sasaki T; Sunouchi T; Ueda M; Kitamura M; Nakayama T; Saito J; Imafuku I
Intern Med; 2021 Oct; 60(20):3321-3324. PubMed ID: 33867389
[TBL] [Abstract][Full Text] [Related]
23. Two pregnancies of an ornithine carbamoyltransferase deficiency disease carrier and review of the literature.
Arhip L; Agreda J; Serrano-Moreno C; Motilla de la Cámara M; Carrascal Fabián ML; Bielza A; Velasco Gimeno C; Camblor M; Bretón Lesmes I; Cuerda C
Nutr Hosp; 2024 Apr; 41(2):489-509. PubMed ID: 38258666
[TBL] [Abstract][Full Text] [Related]
24. The remarkable journey of one female individual with ornithine transcarbamylase deficiency diagnosed post-mortem.
Forsyth R; Peretz RH; Dempsey A; Britton J; Kratz L; Hamosh A; Vernon H; Batshaw ML; Valle D
JIMD Rep; 2023 May; 64(3):233-237. PubMed ID: 37151362
[TBL] [Abstract][Full Text] [Related]
25. Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review.
Ahmed A; Ata F; Gaber M; Petkar M; Mahfouz A; Schirmacher P; Musa S; Hashim A
Curr Probl Cancer; 2022 Jun; 46(3):100847. PubMed ID: 35276469
[TBL] [Abstract][Full Text] [Related]
26. Derivation of healthy hepatocyte-like cells from a female patient with ornithine transcarbamylase deficiency through X-inactivation selection.
Santamaria R; Ballester M; Garcia-Llorens G; Martinez F; Blazquez M; Ribes-Koninckx C; Castell JV; Wuestefeld T; Bort R
Sci Rep; 2022 Feb; 12(1):2308. PubMed ID: 35145162
[TBL] [Abstract][Full Text] [Related]
27. Ornithine transcarbamylase deficiency: A diagnostic odyssey.
Knerr I; Cassiman D
J Inherit Metab Dis; 2022 Jul; 45(4):661-662. PubMed ID: 35734906
[No Abstract] [Full Text] [Related]
28. Chemotherapy in a Breast Cancer Patient Heterozygous Carrier of Ornithine Transcarbamylase Deficiency.
Palka-Kotlowska M; Cabezón-Gutiérrez L; Custodio-Cabello S; Quijada-Fraile P; Chumillas-Calzada S
Cureus; 2020 May; 12(5):e8301. PubMed ID: 32601573
[TBL] [Abstract][Full Text] [Related]
29. [Guidelines for diagnosis, treatment and management of urea cycle disorders in China].
; ; ; ;
Zhonghua Er Ke Za Zhi; 2022 Nov; 60(11):1118-1126. PubMed ID: 36319144
[TBL] [Abstract][Full Text] [Related]
30. Severity-adjusted evaluation of liver transplantation on health outcomes in urea cycle disorders.
Posset R; Garbade SF; Gleich F; Scharre S; Okun JG; Gropman AL; Nagamani SCS; Druck AC; Epp F; Hoffmann GF; Kölker S; Zielonka M; ;
Genet Med; 2024 Apr; 26(4):101039. PubMed ID: 38054409
[TBL] [Abstract][Full Text] [Related]
31. The challenge of understanding and predicting phenotypic diversity in urea cycle disorders.
Posset R; Zielonka M; Gleich F; Garbade SF; Hoffmann GF; Kölker S;
J Inherit Metab Dis; 2023 Nov; 46(6):1007-1016. PubMed ID: 37702610
[TBL] [Abstract][Full Text] [Related]
32. Adult-onset presentation of a urea cycle disorder necessitating intensive care unit admission.
Anderson D; Jain-Ghai S; Sligl WI
Can J Anaesth; 2020 Aug; 67(8):1094-1096. PubMed ID: 32207085
[No Abstract] [Full Text] [Related]
33. Liver involvement in urea cycle disorders: a review of the literature.
Bigot A; Tchan MC; Thoreau B; Blasco H; Maillot F
J Inherit Metab Dis; 2017 Nov; 40(6):757-769. PubMed ID: 28900784
[TBL] [Abstract][Full Text] [Related]
34. A novel
Filingeri D; Mackey S; Soller H; Guarneri-Tragone A; Cooper J; Escobar O; Bedoyan JK
Mol Genet Metab Rep; 2024 Mar; 38():101058. PubMed ID: 38469098
[TBL] [Abstract][Full Text] [Related]
35. Genetic Therapy Approaches for Ornithine Transcarbamylase Deficiency.
Seker Yilmaz B; Gissen P
Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626723
[TBL] [Abstract][Full Text] [Related]
36. Modelling urea cycle disorders using iPSCs.
Duff C; Baruteau J
NPJ Regen Med; 2022 Sep; 7(1):56. PubMed ID: 36163209
[TBL] [Abstract][Full Text] [Related]
37. Clinical and biochemical footprints of inherited metabolic diseases. VIII. Neoplasias.
Jerves T; Blau N; Ferreira CR
Mol Genet Metab; 2022 Jun; 136(2):118-124. PubMed ID: 35422340
[TBL] [Abstract][Full Text] [Related]
38. HNF1A POU Domain Mutations Found in Japanese Liver Cancer Patients Cause Downregulation of
Haque E; Teeli AS; Winiarczyk D; Taguchi M; Sakuraba S; Kono H; Leszczyński P; Pierzchała M; Taniguchi H
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327967
[TBL] [Abstract][Full Text] [Related]
39. Biomarkers for liver disease in urea cycle disorders.
Nagamani SCS; Ali S; Izem R; Schady D; Masand P; Shneider BL; Leung DH; Burrage LC
Mol Genet Metab; 2021 Jun; 133(2):148-156. PubMed ID: 33846069
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
